Automated Liquid-Chromatographic Analyzer Used for Toxicology Screening in a General Hospital: 12 Months' Experience (Drug Monitoring and Toxicology) Automated Liquid-Chromatographic Analyzer Used for Toxicology Screening in a General Hospital: 12 Months' Experience (Drug Monitoring and Toxicology)

Automated Liquid-Chromatographic Analyzer Used for Toxicology Screening in a General Hospital: 12 Months' Experience (Drug Monitoring and Toxicology‪)‬

Clinical Chemistry 1997, March, 43, 3

Clinical Chemistry
    • €2.99
    • €2.99

Publisher Description

For toxicological screening during acute drug poisoning, laboratories must implement rapid and specific methods. Many laboratories use broad-spectrum screening to determine unknown agents in a patient's sample. Several studies have shown that toxicological screening frequently identifies unsuspected drugs in patients with drug overdoses [1,2]. In a majority of cases, all that is required to guide therapy is qualitative drug screening. Some authors have developed methods for toxicological screening [3,4] based on thin-layer chromatography (TLC) separation and ultraviolet (UV) spectral detection, respectively. (3) Toxi-Lab (Irvine, CA) has developed a drug-screening procedure based on liquid-liquid extraction, TLC separation, and reagent-spray detection (sulfuric acid, Draggendorf reagent).

GENRE
Science & Nature
RELEASED
1997
1 March
LANGUAGE
EN
English
LENGTH
16
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
PROVIDER INFO
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
223.1
KB

More Books Like This

Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring
Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring
2012
Standards of Laboratory Practice: Analgesic Drug Monitoring (Nacb Symposium) Standards of Laboratory Practice: Analgesic Drug Monitoring (Nacb Symposium)
Standards of Laboratory Practice: Analgesic Drug Monitoring (Nacb Symposium)
1998
Therapeutic Drug Monitoring in Special Populations (Tdm Conference) Therapeutic Drug Monitoring in Special Populations (Tdm Conference)
Therapeutic Drug Monitoring in Special Populations (Tdm Conference)
1998
Drug Disposition and Pharmacokinetics Drug Disposition and Pharmacokinetics
Drug Disposition and Pharmacokinetics
2011
Safety of St. John's Wort Extract Compared to Synthetic Antidepressants (Review) Safety of St. John's Wort Extract Compared to Synthetic Antidepressants (Review)
Safety of St. John's Wort Extract Compared to Synthetic Antidepressants (Review)
2006
Urinary Cannabinoid Detection Times After Controlled Oral Administration of [[Delta].Sup.9]-Tetrahydrocannabinol to Humans (Drug Monitoring and Toxicology) (Clinical Report) Urinary Cannabinoid Detection Times After Controlled Oral Administration of [[Delta].Sup.9]-Tetrahydrocannabinol to Humans (Drug Monitoring and Toxicology) (Clinical Report)
Urinary Cannabinoid Detection Times After Controlled Oral Administration of [[Delta].Sup.9]-Tetrahydrocannabinol to Humans (Drug Monitoring and Toxicology) (Clinical Report)
2003

More Books by Clinical Chemistry

Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report) Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
Impact of the Third Cholesterol Report from the Adult Treatment Panel of the National Cholesterol Education Program on the Clinical Laboratory (Special Report)
2002
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs) DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
DNA Methylation Changes in Sera of Women in Early Pregnancy are Similar to Those in Advanced Breast Cancer Patients (Technical Briefs)
2004
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs) Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
Colorectal Carcinoma Susceptibility and Metastases are Associated with Matrix Metalloproteinase-7 Promoter Polymorphisms (Technical Briefs)
2003
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial) High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
High-Sensitivity C-Reactive Protein As a Predictor of All-Cause Mortality: Implications for Research and Patient Care (Editorial)
2008
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs) Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
Biological Variation of Tumor Markers and Its Application in the Detection of Disease Progression in Patients with Non-Small Cell Lung Cancer (Technical Briefs)
2005
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial) Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
Hemoglobin Variants and Hemoglobin [a.Sub.1C] Analysis: Problem Solved?(Editorial)
2003